JUBILANT INGREVIA LIMITED is a Chemicals & Petrochemicals company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 4,949 | 4,773 | 4,136 | 4,178 | 4,388 |
| EBITDA (ex other income) | 832 | 547 | 421 | 519 | 554 |
| margin % | 16.8 | 11.5 | 10.2 | 12.4 | 12.6 |
| Owners' profit | 477 | 308 | 183 | 251 | 278 |
| EPS, as reported (₹) | 29.98 | 19.34 | 11.56 | 15.89 | 17.59 |
| ROE % · ROCE % | 19.6 · 27.0 | 11.5 · 14.9 | 6.7 · 9.3 | 8.6 · 11.0 | 8.9 · 10.8 |
| Debt / equity (x) | 0.09 | 0.15 | 0.27 | 0.26 | 0.25 |
| Cash from operations | 453 | 462 | 430 | 508 | 524 |
| Capex | (230) | (481) | (568) | (366) | (299) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 |
| Profit before tax | 80 | 96 | 102 | 100 | 93 | 65 | 112 | 141 |
| Net profit | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 |
| EPS (₹) | 3.73 | 4.39 | 4.69 | 4.75 | 4.40 | 2.97 | 5.47 | 6.70 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Speciality Chemicals | 2,214 | 47.4 |
| Nutrition & Health Solutions | 791 | 16.9 |
| Chemical Intermediates | 1,668 | 35.7 |
| Total, before eliminations | 4,673 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,59,479 | 60.2 | 14.43 | 42.3 | 22.4 | 28.0 | 14.9 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 26 Aug 2026 · 7th AGM held on Aug 26, 2026: all 5 resolutions passed; Rs 2.50 final dividend declared | board shareholder meetings | low | — | — |
| 26 Aug 2026 · Jubilant Ingrevia 7th AGM: All 5 resolutions passed, Rs 2.50 dividend declared | board shareholder meetings | medium | — | — |
| 18 Aug 2026 · Jubilant Ingrevia to buy 40% in Zettaone Technologies for Rs 189.2 Cr | strategic transactions | high | — | — |
| 18 Aug 2026 · Jubilant Ingrevia to buy 40% stake in Zettaone Technologies for INR 189.2 Cr | strategic transactions | high | — | — |
| 4 Aug 2026 · Management to attend Equirus India Conference 2026 on Aug 13-14 | board shareholder meetings | low | — | — |
| 4 Aug 2026 · Jubilant Ingrevia to attend Nuvama India Conference 2026 in Singapore | board shareholder meetings | low | — | — |
| 2 Aug 2026 · Notice of 7th AGM, E-Voting, Record Date and Final Dividend | compliance | minimal | — | — |
| 1 Aug 2026 · AGM notice dispatch to shareholders without registered email - FY26 | compliance | minimal | — | — |
| 1 Aug 2026 · TDS communication on Final Dividend FY 2025-26 | corporate actions | medium | — | — |
| 1 Aug 2026 · Jubilant Ingrevia files BRSR for FY26, ESG targets met | compliance | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| 28.6 |
| SRF LTD | 73,583 | 34.0 | 5.24 | 22.7 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 | 37.5 |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 | 3.00 | 18.8 | 7.0 | 4.4 | 13.0 | 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 33.5 | 23.4 | 68 of 103 | 34% |
| P/B | 3.3 | 2.9 | 61 of 99 | 39% |
| ROCE | 9.5 | 10.3 | 58 of 108 | 47% |
| ROE | 8.9 | 8.1 | 49 of 101 | 52% |
| Debt / Equity | 0.3 | 0.2 | 58 of 101 | 43% |
| EBITDA margin | 16.1 | 15.5 | 48 of 99 | 52% |
| Revenue growth | 25.3 | 24.4 | 42 of 94 | 56% |
| Profit growth | 40.9 | 55.1 | 51 of 92 | 45% |
| Market cap | 10439 | 732 | 16 of 107 | 86% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
